Thymosin Alpha-1 for chronic immune issues — worth the cost?

C
Joined 2026
10 posts
1/11/2026 · 413 views

Thymosin Alpha-1 (TA-1, Zadaxin) is an immune modulator used in Asia and parts of Europe for hepatitis and as an adjunct for immunocompromised patients. It's expensive and obscure in the US but some people use it for chronic immune dysfunction — recurrent viral reactivation, long-COVID symptoms, etc.

Anyone run TA-1 long enough to have an opinion, and did bloodwork (CD4/CD8 ratios, CBC diff, inflammatory markers) actually move?

3 Replies

H
Joined 2025
205 posts
hexaclinicContributor
1/11/2026

TA-1 is one of the few immunomodulators where the clinical evidence is respectable — it's on the essential medicines list in multiple countries. For chronic viral reactivation specifically the case is reasonable. Dose is typically 1.6mg sub-q twice weekly.

Q2 stack
  • CJC-1295 no DAC · 100 mcg · pre-bed · sub-Q
  • Ipamorelin · 200 mcg · pre-bed · sub-Q
  • BPC-157 · 500 mcg · 2x/day · sub-Q
P
Joined 2026
50 posts
1/15/2026

CD4/CD8 ratio moved in a positive direction for me (was inverted, moved toward normal) over 16 weeks at 1.6mg 2x/week. Stopped chasing chronic illness labels and focused on functional metrics. Cost is real.

D
Joined 2025
119 posts
dr_doubtRegular
1/18/2026

If you have actual documented immune dysfunction (low NK activity, chronic EBV reactivation, etc) TA-1 has an evidence-backed argument. For 'I feel tired sometimes' it's overkill.

Sign in to reply.